Combination intracavitary chemotherapy for malignant pleural disease

Area of Science:

• Oncology
• Thoracic Medicine

Background:

• Malignant pleural disease and effusions present a significant challenge in cancer treatment.
• Patients often have poor prognoses and limited treatment options.

Purpose of the Study:

• To evaluate the efficacy and safety of combination intrapleural chemotherapy in heavily pretreated patients with malignant pleural disease.
• To assess the clinical response in patients with ovarian cancer metastatic to the pleura.

Main Methods:

• Seven patients received 12 courses of intrapleural chemotherapy.
• The regimen included cisplatin, cytarabine, and doxorubicin.
• Patients had malignant pleural disease and effusions, with prior heavy pretreatment.

Main Results:

• Two patients with ovarian cancer metastatic to the pleura showed dramatic clinical improvement.
• No local pain, nephrotoxicity, or bone marrow suppression was observed during the trial.
• The combination therapy was generally well-tolerated in this small cohort.

Conclusions:

• Combination intrapleural chemotherapy demonstrated potential benefit for malignant pleural disease.
• Further investigation into intrapleural therapy, particularly with escalated cytarabine doses, is warranted.
• This approach may offer a viable option for select patients with refractory disease.